THEMIS MEDICARE LTD. - 530199 - Compliance Under Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.
In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose disclosure of Related Party Transactions on a consolidated basis for the half year ended March 31, 2021. Themis Medicare Ltd - 530199 - Announcement Under Regulation 30 (LODR)- Intimation For Change In Email Id
With reference to the above subject matter, we would like to inform that the E-mail ID of the Company to be changed from prakash@themismedicare.com to sangameshwar.iyer@themismedicare.com and also update the additional E-mail ID cfoassist@themismedicare.com with immediate effect. We request you to please take on record the aforesaid new E-mail ID on your record and send all the communication addressed to the Company on the new E-mail ID. THEMIS MEDICARE LTD. - 530199 - Announcement under Regulation 30 (LODR)-Newspaper Publication
In terms of Regulations 47 of SEBI (LODR) Regulations, 2015 the company has published the audited Financial Results for the quarter and year ended March 31,2021 in ''Indian Express'' (English) edition dated Friday, May 28, 2021 & in Financial Express'' (Gujarati) edition dated Friday, May 28,2021. Further, in pursuance of Regulation 30 read with Schedule III (A) (12) please find enclosed the copy of Newspaper articles as published in the above mentioned newspapers. THEMIS MEDICARE LTD. - 530199 - Board recommends Dividend
Themis Medicare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 27, 2021, inter alia, has recommended dividend for Financial Year ended March 31, 2021 of Rs. 4.30/- (Re only.) i.e. @ 43% per equity share having face value of Rs. 10/-, aggregating to Rs. 395.10 lacs. The payment is subject to the approval of shareholders at the ensuing AGM. Themis Medicare Ltd - 530199 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotted 5508 Equity Shares to eligible employees'' pursuant to exercise of ESOP Options under Themis ESOS Scheme 2012. Themis Medicare Ltd - 530199 - Financials Results For The Quarter/Year Ended 31.03.2021
1. Approved the Audited Standalone and Consolidated financial results for the Quarter and Year ended 31st March, 2021. A copy of Audited Standalone and Consolidated Financial Results for the Quarter and Year ended 31st March, 2021 is enclosed herewith. (Annexure I) 2. Recommended dividend for Financial Year ended 31.03.2021 of Rs.4.30/- (Re only.) per equity share having face value of Rs.10/- each, aggregating to Rs. 395.10 lacs. The payment is subject to the approval of shareholders at the ensuing AGM. 3. Considered the appointment of M/s. B.J. D. Nanabhoy & Co., Cost Accountant as the Cost Auditors of the Company for the FY 2021-22. 4. Appointed Mr. Shirish Shetye of M/s. SAV & Associates LLP, Practicing Company Secretaries, as the Scrutinizer for conducting E-Voting and Poll at the 51st Annual General Meeting. 5. Allotted 5508 Equity Shares to eligible employees'' pursuant to exercise of ESOP Options under Themis ESOS Scheme 2012. Themis Medicare Ltd - 530199 - Outcome Of The Board Meeting
1. Approved the Audited Standalone and Consolidated financial results for the Quarter and Year ended 31st March, 2021. A copy of Audited Standalone and Consolidated Financial Results for the Quarter and Year ended 31st March, 2021 is enclosed herewith. (Annexure I) 2. Recommended dividend for Financial Year ended 31.03.2021 of Rs.4.30/- (Re only.) per equity share having face value of Rs.10/- each, aggregating to Rs. 395.10 lacs. The payment is subject to the approval of shareholders at the ensuing AGM. 3. Considered the appointment of M/s. B.J. D. Nanabhoy & Co., Cost Accountant as the Cost Auditors of the Company for the FY 2021-22. 4. Appointed Mr. Shirish Shetye of M/s. SAV & Associates LLP, Practicing Company Secretaries, as the Scrutinizer for conducting E-Voting and Poll at the 51st Annual General Meeting. 5. Allotted 5508 Equity Shares to eligible employees'' pursuant to exercise of ESOP Options under Themis ESOS Scheme 2012. Themis Medicare Ltd - 530199 - Announcement under Regulation 30 (LODR)-Newspaper Publication
In terms of Regulation 47 of the SEBI (LODR) Regulations, 2015, the Company has published the notice in the 'Indian Express' (English) Newspaper edition dated May 20, 2021 & in ''Financial Express'' (Gujarati) edition dated May 20, 2021 informing about the Board Meeting scheduled to be held on Thursday, 27th May, 2021, inter alia to consider and approve the Audited Financial Results for the Quarter/Year ended on 31st March, 2021. Further, in pursuance of Regulation 30 read with Schedule III (A) (12) please find enclosed the copy of Newspaper articles as published in above mentioned newspapers Themis Medicare Ltd - 530199 - Board to consider Dividend
Themis Medicare Ltd has informed BSE that a meeting of the Board of Directors of the Company is scheduled to be held on May 27, 2021 inter alia, to transact the following business:1. To consider the Audited Financial Results for the Quarter/Year ended on March 31, 2021.2. To consider recommending Dividend if any on the equity shares of the Company for the financial year 2020-21.Further, in continuation of the Company's Letter dated March 31, 2021, the Trading Window in respect of dealing in the Company's Securities was closed for all Directors/Designated Employees from the opening of the trading hours on April 01, 2021, which shall remain closed till the closure of trading hours on May 29, 2021 (both days inclusive) i.e. till the completion of 48 hours after the declaration of financial results as per the policy for prohibition of Insider Trading ("the Code") adopted by the Company pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time.